(Q40378564)

20 September 2017

title

The safety of H(2)-blockers use during pregnancy (English)

1 reference

20 September 2017

0 references

2

Rafael Gorodischer

1 reference

20 September 2017

4

Eyal Sheiner

1 reference

20 September 2017

5

Arnon Wiznitzer

1 reference

20 September 2017

3

Gideon Koren

1 reference

20 September 2017

7

Amalia Levy

1 reference

20 September 2017

1

Ilan Matok

1 reference

20 September 2017

Elia Uziel

6

1 reference

20 September 2017

publication date

29 September 2009

1 reference

The Journal of Clinical Pharmacology

20 September 2017

published in

1 reference

20 September 2017

volume

50

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

81-87

1 reference

Gastrointestinal motility disorders during pregnancy

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Gastroesophageal reflux disease presenting with intractable nausea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

The placental transfer of cimetidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Outcome of pregnancy after first trimester exposure to H2 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Safety of acid-suppressing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Guidelines for case classification for the National Birth Defects Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Maternal age and non-chromosomal birth defects, Atlanta--1968-2000: teenager or thirty-something, who is at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Effects of gestational diabetes on perinatal morbidity reassessed. Report of the International Workshop on Adverse Perinatal Outcomes of Gestational Diabetes Mellitus, December 3-4, 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Use of Medicaid data for pharmacoepidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

Comparing Sources of Drug Data about the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009350483

21 January 2018

Identifiers

DOI

10.1177/0091270009350483

1 reference

20 September 2017

1 reference